NCT00507169
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified
Clinical trial condition
Urinary Bladder, Overactive
Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.
599 public trials
57 recruiting studies
Urinary Bladder, Overactive trial results
Completed
The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
NCT00914667
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00479505
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
- Locations
-
- Pfizer Investigational Site Miranda, New South Wales, Australia
- Pfizer Investigational Site Kippa-Ring, Queensland, Australia
- Pfizer Investigational Site Victoria, British Columbia, Canada
- Pfizer Investigational Site Barrie, Ontario, Canada
NCT00901251
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Beijing, China
- Chongqing, China
- Shanghai, China
- Shenyang, China
Completed
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
NCT00231491
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- RAYMOND POINCARE Hospital Garches, France
NCT00611026
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Enterprise, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Montgomery, Alabama, United States
- Pfizer Investigational Site Chandler, Arizona, United States
NCT00806494
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
- Locations
-
- Pfizer Investigational Site Ely, Cambridgeshire, United Kingdom
- Pfizer Investigational Site Crewe, Cheshire, United Kingdom
- Pfizer Investigational Site Fowey, Cornwall, United Kingdom
- Pfizer Investigational Site Penzance, Cornwall, United Kingdom
NCT01122563
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Bandung, Indonesia
- Jakarta, Indonesia
- Surabaya, Indonesia
NCT00553657
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Randwick, Sydney, New South Wales, Australia
Completed
A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder
NCT01214265
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- The Incontinence and Pelvic Support Institute Mission Viejo, California, United States